Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study

References

• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465-74
   PubMed Web of Science ®Google Scholar
• Fernandes L, Hagen KB, Bijlsma JW, et al. European League Against Rheumatism (EULAR). EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:1125-35
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-88
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;19:CD005321
   Google Scholar
• Campbell J, Bellamy N, Gee T. Differences between systematic reviews on hyaluronan/hyaluronic acid/hylan. Osteoarthritis Cartilage 2007;15:1424-36
   PubMed Web of Science ®Google Scholar
• Abatea M, Pulcinib D, Di Iorioc A, Schiavone C. Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharmaceut Design 2010;16:631-40
   PubMed Web of Science ®Google Scholar
• Arnold W, Fullerton DS, Holder S, May CS. Viscosupplementation: managed care issues for osteoarthritis of the knee. J Manag Care Pharm 2007;13(Suppl):S3-S19
   PubMed Web of Science ®Google Scholar
• Divine JG, Zazulak BT, Hewett TE. Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res 2006;455:113-22
   Web of Science ®Google Scholar
• Espallargues M, Pons JMV. Efficacy and safety of viscosupplementation with hylan G-F20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003;19:41-56
   PubMed Web of Science ®Google Scholar
• Nüesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515
   PubMed Web of Science ®Google Scholar
• Reichenbach S, Blank S, Rutjes AWS, et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007;57:1410-18
   PubMed Web of Science ®Google Scholar
• Rutjes AWS, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med 2012;157:180-91
   PubMed Web of Science ®Google Scholar
• Strand V, Conaghan PG, Lohmander LS, et al. An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee. Osteoarthritis Cartilage 2006;14:859-66
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technologies in Health. Rapid Response Report: Viscosupplementation for the Treatment of Osteoarthritis of the Knee: Clinical Effectiveness and Guidelines. 13 February 2014. Available at: www.cadth.ca [Last accessed 29 May 2015]
   Google Scholar
• Bannuru RR, Vaysbrot EE, Sullivan MC, et al. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2013;43:593-599
   PubMed Web of Science ®Google Scholar
• Miller LE, Block JE. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord 2013;6:57-63
   PubMedGoogle Scholar
• Printz JO, Lee JJ, Knesek M, et al. Conflict of interest in the assessment of hyaluronic acid injections for osteoarthritis of the knee: an updated systematic review. J Arthroplasty 2013;28(8Suppl):30-3
   Web of Science ®Google Scholar
• Trigkilidas D, Anand A. The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain. Ann R Coll Surg Engl 2013;95:545-51
   PubMed Web of Science ®Google Scholar
• Cheng OT, Souzdalnitski D, Vrooman B, Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med 2012;13:740-53
   PubMed Web of Science ®Google Scholar
• Colen S, van den Bekerom MP, Mulier M, et al. Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products. BioDrugs 2012;26:257-68
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Natov NS, Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009;61:1704-11
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014;22:363-388
   Google Scholar
• National Guideline Clearinghouse. Guideline Summary: American Academy of Orthopaedic Surgeons Clinical Practice Guideline on Treatment of Osteoarthritis of the Knee. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ), 1996 (Revised 2013)
   Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465-74
   PubMed Web of Science ®Google Scholar
• National Guideline Clearinghouse. Guideline Summary: Knee Disorders. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ), 1997 (Revised 2011)
   Google Scholar
• National Guideline Clearinghouse. Guideline Summary: Knee & Leg (Acute & Chronic). Rockville (MD): Agency for Healthcare Research and Quality (AHRQ), 1997 (Revised 2013)
   Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99
   PubMed Web of Science ®Google Scholar
• Brand Caroline, Buchbinder Rachelle, Wluka Anita, et al. Guideline for the Non-Surgical Management of Hip and Knee Osteoarthritis. South Melbourne (AU): The Royal Australian College of General Practitioners, 2009
   Google Scholar
• Eisenberg Center, Oregon Health & Science University. Three Treatments for Osteoarthritis of the Knee: Evidence Shows Lack of Benefit. AHRQ Pub. No. 09-EHC001-3. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ), 2009
   Google Scholar
• Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 1999;21:1549-62
   PubMed Web of Science ®Google Scholar
• Raynauld JP, Torrance GW, Walker V, et al. A prospective, randomized, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506-17
   PubMed Web of Science ®Google Scholar
• Torrance GW, Raynauld JP, Walker V, et al. A prospective, randomized, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 2 of 2): economic results. Osteoarthritis Cartilage 2002:10:518-27
   PubMed Web of Science ®Google Scholar
• Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 2010;69:113-19
   PubMed Web of Science ®Google Scholar
• Pal S, Thuppal S, Reddy KJ, et al. Long-term (1-year) safety and efficacy of a single 6-ml injection of hylan G-F 20 in Indian patients with symptomatic knee osteoarthritis. Open Rheumatol J 2014;8:54-68
   PubMedGoogle Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1988;1:95-108
   Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40
   PubMed Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care 1992;30:473-83
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63
   PubMed Web of Science ®Google Scholar
• Grootendorst P, Marshall D, Pericak D, et al. A model to estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in patients with osteoarthritis of the knee. J Rheumatol 2007;34:534-42
   PubMed Web of Science ®Google Scholar
• Marshall D, Pericak D, Grootendorst P, et al. Validation of a prediction model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip. Value Health 2008;11:470-7
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635-41
   PubMed Web of Science ®Google Scholar
• Bellamy N, Hochberg M, Tubach F, et al. Development of multidomestic definitions of Minimal Clinically Important Improvement (MCII) and Patient Acceptable Symptomatic State (PASS) in osteoarthritis. Arthritis Care Res (Hoboken) 2015;67:972-80
   PubMed Web of Science ®Google Scholar
• Bellamy N, Bell M, Goldsmith C, et al. Evaluation of WOMAC 20, 50, 70 Response Criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Ann Rheum Dis 2005;64:881-5
   PubMed Web of Science ®Google Scholar
• Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. OsteoArthritis Cartilage 2004;12:389-99
   PubMed Web of Science ®Google Scholar
• Bellamy N, Bell MJ, Pericak D, et al. BLISS Index for analysing knee osteoarthritis trials data. J Clin Epidemiol 2007;60:124-32
   PubMed Web of Science ®Google Scholar
• Bellamy N, Bell MJ, Goldsmith CH. BLISS index using WOMAC index detects between-group differences at low-intensity symptom states in osteoarthritis. J Clin Epidemiol 2010;63:566-74
   PubMed Web of Science ®Google Scholar
• Bellamy N, Wilson C, Hendrikz J. Population-based normative values for the Western Ontario and McMaster (WOMAC) Osteoarthritis Index (Part 1). Semin Arthritis Rheum 2011;41;139-48
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502
   PubMed Web of Science ®Google Scholar
• Bellamy N, Goldstein L, Tekanoff R. CME-driven skills acquisition and impact on improved patient outcomes. J Contin Educ Health Professions 2000;20:52-61
   PubMedGoogle Scholar
• Bellamy N, Wilson C, Hendrikz J, et al. Electronic data capture (EDC) using cellular technology: implications for clinical trials and practice, and preliminary experience with the m-WOMAC Index in hip and knee OA patients. Inflammopharmacology 2009;17:93-9
   PubMedGoogle Scholar
• Bellamy N, Wilson C, Hendrikz, J, et al. WOMAC NRS 3.1 Osteoarthritis index delivered by mobile phone (m-WOMAC) is valid, reliable and responsive. J Clin Epidemiol 2011;64:182-90
   PubMed Web of Science ®Google Scholar
• Bellamy N, Patel B, Davis T, et al. Electronic data capture (EDC) using the WOMAC NRS 3.1 Index (m-WOMAC): a pilot study of repeated independent remote data capture in OA. Inflammopharmacology 2010;18:107-11
   PubMedGoogle Scholar
• IBM Corp. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp., 2013
   Google Scholar
• Welch KB, West B, Galecki AT. Linear Mixed Models: A Practical Guide Using Statistical Software. Boca Raton: Chapman & Hall/CRC, 2007
   Google Scholar
• Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012;10:28-55
   PubMed Web of Science ®Google Scholar
• Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hyalgan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85
   PubMed Web of Science ®Google Scholar
• Bellamy N. Principles of clinical outcome assessment. In: Hochberg MC (ed.) Rheumatology, 6th edn. London: Elsevier Ltd, 2015:9-19
   Google Scholar
• Mazzuca SA, Brandt KD, Katz BP, et al. Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug. Arthritis Rheum 2004;51:933-40
   PubMed Web of Science ®Google Scholar
• Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6
   PubMed Web of Science ®Google Scholar
• Dougados M, Nguyen M, Berdah L, et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Arthritis Rheum 2001;44:2539-47
   PubMed Web of Science ®Google Scholar
• Reginster JY, Badurski J, Bellamy N, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013;72:179-86
   PubMed Web of Science ®Google Scholar
• Pavelká K, Gatterová J, Olejarová M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year randomised, placebo-controlled, double-blind study. Arch Int Med 2002;162:2113-23
   PubMed Web of Science ®Google Scholar